Immunological medicine
Drug retention rate of Janus kinase inhibitors in patients with rheumatoid arthritis: the KEIO-RA cohort study.
Satoshi Takanashi, Masatoshi Kawai, Mitsuhiro Akiyama, Yasushi Kondo, Shuntaro Saito, Masaru Takeshita, Jun Kikuchi, Hironari Hanaoka, Yuko Kaneko
Published: 202510.1080/25785826.2025.2590230
Abstract
This study aimed to investigate the effectiveness and safety of Janus kinase inhibitors (JAKis) in patients with rheumatoid arthritis (RA) in the real world. All consecutive patients with RA from the KEIO-RA cohort who had received a JAKi from July 2…
Preview only. Read the full abstract at the source